ES2090966T3 - Formulaciones liposomicas con piroxicam. - Google Patents

Formulaciones liposomicas con piroxicam.

Info

Publication number
ES2090966T3
ES2090966T3 ES93903912T ES93903912T ES2090966T3 ES 2090966 T3 ES2090966 T3 ES 2090966T3 ES 93903912 T ES93903912 T ES 93903912T ES 93903912 T ES93903912 T ES 93903912T ES 2090966 T3 ES2090966 T3 ES 2090966T3
Authority
ES
Spain
Prior art keywords
piroxicam
formulations
liposomic
liposomic formulations
phosfolipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93903912T
Other languages
English (en)
Spanish (es)
Inventor
Giovanni Lucchetti
Giuseppe Assogna
Pietro Bagnato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Cilag SpA
Original Assignee
Janssen Cilag SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Cilag SpA filed Critical Janssen Cilag SpA
Application granted granted Critical
Publication of ES2090966T3 publication Critical patent/ES2090966T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES93903912T 1992-02-12 1993-02-04 Formulaciones liposomicas con piroxicam. Expired - Lifetime ES2090966T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92200398 1992-02-12

Publications (1)

Publication Number Publication Date
ES2090966T3 true ES2090966T3 (es) 1996-10-16

Family

ID=8210420

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93903912T Expired - Lifetime ES2090966T3 (es) 1992-02-12 1993-02-04 Formulaciones liposomicas con piroxicam.

Country Status (13)

Country Link
US (1) US5505960A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH07503952A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1075633A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE137959T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU661755B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2129624A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69302677T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0625898T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2090966T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL104688A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9300707A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW262382B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA93954B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100173876A1 (en) * 2000-12-19 2010-07-08 The Board Of Regents Of The University Of Texas System Oil-based nsaid compositions and methods for making and using same
US20040077604A1 (en) * 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
SI1343529T1 (sl) * 2000-12-19 2009-04-30 Univ Texas NSAID formulacije, ki vsebujejo lecitinska olja, za zaščito gastrointestinalnega trakta in zagotovitev povečanja terapevtske aktivnosti
EP1653975A4 (en) * 2003-07-31 2006-10-25 Univ Texas COMPOSITIONS AND METHODS FOR TREATING, PREVENTING AND / OR PREVENTING CANCER, THE USE OF CANCER OR THE SYMPTOMS OF CANCER
WO2007124423A2 (en) 2006-04-21 2007-11-01 Smithkline Beecham Corporation Il-8 receptor antagonists
WO2010056833A1 (en) * 2008-11-12 2010-05-20 Archer Daniels Midland Company Lecithin and plasticizer compositions and methods
CN101637451B (zh) * 2009-06-12 2011-03-30 陶灵刚 一种氯诺昔康脂质体药物组合物及其固体制剂
US8956600B2 (en) 2009-08-10 2015-02-17 Taiwan Liposome Co. Ltd. Ophthalmic drug delivery system containing phospholipid and cholesterol
US8906397B2 (en) 2011-02-07 2014-12-09 Professional Compounding Centers of America, Ltd Permeation enhancers for topical formulations
US8871811B2 (en) 2011-02-07 2014-10-28 Professional Compounding Centers of America, Ltd Permeation enhancers for topical formulations
US20120201871A1 (en) * 2011-02-07 2012-08-09 Professional Compounding Centers Of America, Ltd. Permeation enhancers with liposomes for topical formulations
CN103957888B (zh) 2011-09-29 2017-11-21 PLx 制药公司 用于将药物沿胃肠道靶向释放的pH依赖性载体、其组合物及其制备和应用
US9415054B2 (en) 2013-06-13 2016-08-16 Professional Compounding Centers Of America (Pcca) Piroxicam transdermal composition to treat plantar fasciitis
EP4125820A4 (en) 2020-03-26 2024-04-10 PLx Opco Inc. Pharmaceutical carriers capable of ph dependent reconstitution and methods for making and using same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3699230A (en) * 1971-03-12 1972-10-17 Robins Co Inc A H Dimethylisosorbide solvent for muscle relaxant drugs
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
EP0249561B1 (en) * 1986-06-12 1992-05-13 The Liposome Company, Inc. Compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
US4963297A (en) * 1987-12-22 1990-10-16 The Liposome Company, Inc. Spontaneous vesticulation of multilamellar liposomes
BE1000381A4 (fr) * 1987-03-13 1988-11-16 Pharlyse Sa Preparation pharmaceutique a base d'indometacine.
US4783450A (en) * 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators

Also Published As

Publication number Publication date
ZA93954B (en) 1994-08-11
ATE137959T1 (de) 1996-06-15
DK0625898T3 (da) 1996-06-03
CA2129624A1 (en) 1993-08-19
TW262382B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1995-11-11
DE69302677D1 (de) 1996-06-20
MX9300707A (es) 1994-01-31
AU661755B2 (en) 1995-08-03
DE69302677T2 (de) 1996-10-02
JPH07503952A (ja) 1995-04-27
IL104688A0 (en) 1993-06-10
US5505960A (en) 1996-04-09
AU3495093A (en) 1993-09-03
CN1075633A (zh) 1993-09-01

Similar Documents

Publication Publication Date Title
ES2090966T3 (es) Formulaciones liposomicas con piroxicam.
ES2191979T3 (es) Sistema de administracion de acido linoleico conjugado en preparaciones cosmeticas.
ES2092386T3 (es) Composicion para combatir el envejecimiento, que actua sobre las capas superficiales y profundas de la piel, su utilizacion.
BR9207070A (pt) Sistema para implante sacral
HUP9900925A2 (hu) Napfényt szűrő készítmények
IT1275096B (it) "sistema antisismico per strutture quali edifici, viadotti, serbatoi esimili"
DK1124582T3 (da) Konserveringssystem til topisk indgivelige farmaceutiske præparater
FI961282L (fi) Transdermaalinen terapeuttinen systeemi, jossa on asetyylisalisyylihappo vaikuttavana aineena
ES2117426T3 (es) Forma cristalina de la sal anhidra compuesta de los acidos 7-((1a,5a,6a)-6-amino-3-azabiciclo(3.1.0.)hex-3-il)-6-fluoro-1-(2,4-difluorofenil)-1,4-dihidro-4-oxo-1,8-naftiridina-3-carboxilico y metanosulfonico.
ES2091019T3 (es) Formulaciones liposomicas de itraconazol.
BR9303646A (pt) Sistema de fundação para plataformas de pernas atirantadas
IT1274960B (it) Sistema per il controllo delle emissioni per piccoli motori
PT910367E (pt) Uso de acetato de vitamina e
BR9608255A (pt) Sistema terapéutico transdérmico (stt) para a administração de testosterona
NO931011L (no) 7-okso-7h-pyrido(1,2,3-de)(1,4)benzoksacin-6-karbonsyrer og -estere
ES2173586T3 (es) Derivados de ciclohexandiol.
ES2141225T3 (es) Formulacion solida para la proteccion de cultivos.
AU7989494A (en) Oil-in-water formulation for topical application
FR2602814B1 (fr) Abri enterre notamment pour aeronefs, tels que des avions de combat
FI933155A7 (fi) Uudet jäädytysainekoostumukset
GB9402351D0 (en) Formulations for the topical delivery of avermectins
IT1255762B (it) Formulazioni liposomiche di piroxicam.
ITNO930001V0 (it) Sistema standard per l'ombreggiatura di autoveicoli
ES1020924Y (es) Dispositivo para el refuerzo de forjados.
BR1100150A (pt) Formulação tópica.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 625898

Country of ref document: ES

FG2A Definitive protection

Ref document number: 625898

Country of ref document: ES